Clinical Trial Detail

NCT ID NCT02121418
Title Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications

acute myeloid leukemia

bone marrow cancer

Therapies

Cytarabine + Decitabine

Age Groups: senior

No variant requirements are available.